SHIN-ETSU-CHEMICAL
Shin-Etsu Chemical Co., Ltd., (Head Office: Tokyo; President: Yasuhiko Saitoh) has developed a new series of products, the KCP Series, a new vulcanization type of one-component liquid silicone rubber.
One-component liquid silicone rubber cures at room temperature by reacting to the atmospheric humidity. After curing, because it has superior combined characteristics, including heat resistance, cold resistance, weather resistance and outstanding electrical properties, it is used as adhesive/sealing materials and coating materials in such products as component parts for electric vehicles (EV), semiconductors, and electric/electronics. Furthermore, because it cures at room temperature, it is not necessary to have a heating furnace and ultraviolet (UV) irradiation equipment. Accordingly, these new products will contribute to reducing environmental impact.
The KCP Series of products are a type that releases cyclopentanone*1 at the time of the curing reaction. This new product series will meet the expectations of our customers with its improved vulcanization characteristics, higher level of safety and excellent handleability compared to existing products.*2 The main characteristics of these new products are as follows:
1: The vulcanization speed is fast and also the adhesion develops quickly, and thus work efficiency improves. The tack-free time*3 of KCP-102 is 3 minutes, ½ of the time of the existing KE-4898-W*4 product.
2: The odor that is generated at the time of curing is lower, and has a higher level of safety.
3: Because the ignition temperature is high, at more than 70 ℃, the handling time and effort needed during the time of transport and storage can be reduced.
4: It exhibits good adhesion with various resins and also there are almost no corrosive effects on metals.*5
There are 3 products lined up in the KCP Series according to their viscosity index: KCP-100 (low viscosity), KCP-101 (mid-viscosity) and KCP-102 (paste type). All of them are tube-type, and one can work simply by pushing the contents out from the tube-type container. Going forward, Shin-Etsu Chemical will continue to strive to meet the requests of our customers and develop products that have various added functions as we work to expand the line-up of our products.
Shin-Etsu Chemical will continue to endeavor to enhance our ability to contribute to the solution of various social and customer issues by developing and supplying advanced functional silicone products through making full use of the technological power and knowhow that Shin-Etsu has nurtured up to now, as we work to further contribute to the realization of the sustainability of society.
Footnotes:
*1 Cyclopentanone is an organic compound represented by the chemical formula (CH2 )4 CO. It is one of the cyclic ketones and is a volatile colorless liquid.
*2 Existing products include types of acetic acid, oxime, alcohol and acetone, and each have their own characteristics.
*3 It is the time that it takes until when one touches the surface, it will not stick to one’s finger.
*4 Curing Condition: 23℃/50%Relative Humidity
*5 Metal substrates should be tested prior to use with this product to insure performance.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220329006080/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deepfakes Already Hitting Businesses as Often as Traditional Fraud, Regula Survey Finds17.9.2025 08:00:00 CEST | Press release
Fresh survey data from Regula, a global developer of identity verification (IDV) solutions and forensic devices, shows that the line between traditional fraud and impersonation attacks has vanished. Identity spoofing, biometric fraud, and AI-powered deepfakes have already struck one in three organizations worldwide, catching up with long-standing fraud tactics like forged documents and social engineering. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916314726/en/ Regula’s survey shows that impersonation attacks overtake traditional fraud schemes. Three impersonation-driven tactics now dominate the fraud playbook, each exploiting weaknesses in verification: Identity spoofing (reported by 34% of organizations) — Holding up a printed photo, replaying a video, or showing a screen image to a camera. Often used to mass-open accounts for scams or mule networks. Biometric fraud (34%) — Physical deceptions like fake fingerprints
Overture Life Launches European Preorder Waitlist for DaVitri, the World’s First Microfluidics-Based Automated Vitrification Platform17.9.2025 07:00:00 CEST | Press release
Ahead of receipt of anticipated CE Mark, European customers can begin requesting DaVitri to expand patient access to high-quality IVF Overture Life, the innovator modernizing IVF to optimize reproductive freedom, today announced the launch of its European preorder waitlist for DaVitri, the world’s first automated vitrification platform. The waitlist ensures in vitro fertilization (IVF) facilities will be among the first in Europe to harness DaVitri to reduce manual workloads for their embryologists while eliminating operator variability, thereby providing patients with faster, more consistent procedures. As infertility rates spike worldwide, interest in egg freezing continues to rise while the infrastructure to support it lags behind. Egg freezing requires vitrification, typically a time-intensive, manual process vulnerable to human error that can only be performed by extensively trained embryologists. This has resulted in variability in egg and embryo survival rates that directly impa
Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 202517.9.2025 07:00:00 CEST | Press release
Across both STOP-HS1 and STOP-HS2, povorcitinib treatment resulted in continued clinically meaningful and statistically significant improvements for patients with active moderate to severe hidradenitis suppurativa (HS) through Week 24At Week 24, nearly 60% of efficacy-evaluable patients among both povorcitinib treatment groups achieved HiSCR50Additionally, patients treated with povorcitinib achieved HiSCR75 (31.0%-40.3%), HiSCR90 (13.8%-27.7%) and HiSCR100 (9.2%-21.3%) through Week 24Povorcitinib-treated patients also achieved greater improvements in skin pain by the first visit (Week 3) through Week 24 with 62%-70% achieving mild or no pain at Week 24 Incyte (Nasdaq:INCY) today announced new 24-week interim data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). These data will
Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin17.9.2025 07:00:00 CEST | Press release
Results from a real-world clinical study conducted in China, to be presented at the European Academy of Dermatology and Venereology (EADV) 2025 Congress, reveal that modern lifestyles and environmental triggers significantly impact individuals with sensitive skin1 Data show that people with sensitive skin living in modern environments have higher levels of inflammation compared to those living traditional, less stressful lifestyles1 This first-of-its-kind study was conducted by Galderma’s Global Sensitive Skincare Faculty (GSSF) as part of the company’s commitment to transforming the understanding and care of sensitive skin1 Galderma today announced new data from a first-of-its-kind real-world clinical study conducted in China assessing the biological impact of different lifestyles and their associated environmental factors on individuals with sensitive skin.1 Results from the study, conducted by dermatology experts from Galderma’s Global Sensitive Skincare Faculty (GSSF), will be pres
Ant International Recognized as an Inaugural Foreign Institution Partner by China’s Cross-Border Interconnection Payment Gateway17.9.2025 06:24:00 CEST | Press release
Expanded direct connection enables Alipay+ to help global wallets build China merchant networkAnt is the largest player in the CPG scheme in terms of coverage, use cases and business volume Ant International is appointed as an inaugural foreign Institution Partner (FIP) of China’s Cross-border Interconnection Payment Gateway (CPG), under the guidance of the People’s Bank of China and the Payment & Clearing Association of China (PCAC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916704996/en/ Eric Jing, Chairman of Ant Group and Ant International, and Cyril Han, CEO of Ant Group, celebrating China's Top International consumer destinations with card and wallet partners. Ant International and Alipay are the largest player in the CPG scheme with the largest number of card network and wallet partners, the broadest use cases and largest business volume. The new CPG scheme is designed to raise connection efficiency and improv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom